Business
Result of WRAP Retail Offer
Result of WRAP Retail Offer.
About this update from Physiomics Plc
[{"type":"text","content":"\n\nUnless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 13 February 2025.\n \n17 February 2025\n \nPhysiomics plc\n \n(\"Physiomics\" or the \"Company\")\n \nResult of WRAP Retail Offer\n \nPhysiomics plc (AIM: PYC), is pleased to announce, further to the announcements made on 13 February 2025, the completion of the WRAP Retail Offer, at the same price as the previously announced Placing (together the \"Fundraise\"). The WRAP Retail Offer, which closed at 11 a.m. today, has raised aggregate gross proceeds of £70,000 through the issue of a total of 14,000,000 new Ordinary Shares, alongside the previously announced Placing of £430,000. The WRAP Retail Offer was slightly oversubscribed and was therefore subject to a small scale back.\n \nThe Fundraise, which is conditional on Admission, raised gross proceeds of, in aggregate, £500,000, via the issue of 86,000,000 Placing Shares pursuant to the Placing and 14,000,000 WRAP Retail Offer Shares pursuant to the WRAP Retail Offer.\n \nUse of Proceeds\nIn order to further develop its business and accelerate growth, the Company is raising funds to carry out the following activities and for general working capital:\n· Mathematical Modelling Consulting Service\no Recruitment of further technical team members to accelerate the conversion of the pipeline and support service delivery;\no Investment in Business Development and Marketing to build and strengthen the pipeline, expand into new therapeutic areas, further develop its data science offering and refresh messaging; and\no Explore strategic options to accelerate the growth of modelling services.\n· Biostatistics Consulting Service\no Organic growth of the service though Business Development and Marketing to acquire clients; and\no Explore strategic options to accelerate the growth of biostatistics services.\n· Personalised Medicine Tool Development\no Explore a deeper relationship with DoseMe to develop models to be implemented on their platform; and\no Implementation of the Company's current personalised dosing tool on the DoseMeRx Platform enabling it to be made available to clinicians across the ...